Cito Capital Group, LLC Charles River Laboratories International, Inc. Transaction History
Cito Capital Group, LLC
- $272 Million
- Q4 2024
A detailed history of Cito Capital Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 1,150 shares of CRL stock, worth $137,356. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,150
Previous 1,150
-0.0%
Holding current value
$137,356
Previous $227,000
6.61%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
50.3MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$736 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$608 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$261 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$216 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$212 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.08B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...